Table 1.
Parameters | Group1 (n = 50) | Group2 (n = 50) | p Value |
---|---|---|---|
Age (Years) | 50.48 ± 13.69 | 49.82 ± 12.17 | 0.245b |
Male:Female | 35:15 | 36:14 | 0.826b |
O Blood group | 30 (60%) | 20 (40%) | 0.071b |
Non O Blood group (AB,B &A) | 20 (40%) | 30 (60%) | |
Diabetes mellitus | 18 (36%) | 19 (38%) | 0.869b |
HbSAg + ve | 00 | 01 | |
HCV + ve | 01 | 01 | |
HIV + ve | 00 | 01 | |
Kt/V | 1.21 ± 0.22 | 1.23 ± 0.26 | 0.236b |
Dialysis vintage(months) | 49.08 ± 10.02 | 49.32 ± 15.50 | 0.985b |
S.Creatinine (mg/dl) | 6.15 ± 2.31 | 6.37 ± 2.06 | 0.566b |
S.Urea (mg/dl) | 75.72 ± 12.75 | 87.36 ± 18.82 | 0.391b |
Hemoglobin (g/dl) | 10.97 ± 2.06 | 10.04 ± 1.87 | 0.021a |
aSignificant at the 0.05 probability level. bNS-Not significant at the 0.05 probability level.
Group 1= ESRD patients with well functioning fistulas; Group 2= ESRD patients with failed AVF.